VENMAXDRUGSPHARMACEUTICALSLTD logo

Venmax Drugs & Pharmaceuticals Ltd

VENMAXDRUGSPHARMACEUTICALSLTD·NSE·
0.00 +0.00 (+0.00%)
Market Cap23.83 Cr
PE Ratio83.40
Volume
Day High - Low
52W High-Low36.96 - 14.10
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
2.2/10
Poor
Fair Value
Sign in to see
ROE
2.70%
Weak
P/E
83.40x
Expensive
Debt / Equity
0.02
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Poor

Price performance

52W14.10
36.96
DocStoX take

Held back by valuation (1.2). Scored on 4 of 5 measures.

DocStoX score

Medium confidence
2.2
/10
Poor
Quality
Weak
ROE 2.7%
Valuation
Expensive
P/E 83.4×
Growth
Slow
Revenue +116.1% 5Y CAGR
Risk
Elevated
D/E 0.02
Momentum
No data
No technical indicators

Scored on 4 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹24 Cr
52W High / Low
₹37 / ₹14
Dividend Yield
0.00%
Promoter Holding
10.46%
EPS (TTM)
₹-0.02
Book Value
₹14.37

Key highlights

  • Revenue compounding 116% a year
  • Low leverage — D/E 0.02
  • Quality is weak (1.3/10)
  • Valuation is weak (1.2/10)
2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Venmax Drugs & Pharmaceuticals Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.